FDA Restricts J&J’s COVID-19 Vaccine Over Risk of Blood Clots

FDA Restricts J&J’s COVID-19 Vaccine Over Risk of Blood Clots
A woman receives a COVID-19 vaccine in Los Angeles, Calif., on March 25, 2021. Lucy Nicholson/Reuters
Jack Phillips
Updated:
0:00
The Food and Drug Administration (FDA) announced on May 5 that it will restrict the use of the Johnson & Johnson COVID-19 vaccine to adults who can’t receive mRNA vaccines, because of the risk of potentially life-threatening side effects with the J&J shot.

The agency said the COVID-19 vaccine can now only be administered to people aged 18 years of age and older who can’t receive either the Moderna or Pfizer vaccines, both of which are two-dose vaccines and use mRNA technology. J&J’s single-shot vaccine uses adenovirus technology.

Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics